EX-10.57 3 d903564dex1057.htm EX-10.57 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under Execution Version SUPPLY AGREEMENTSupply Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020THIS SUPPLY AGREEMENT (“Agreement”) is made and entered into effective as of October 17, 2014 (the “Effective Date”), by and between Nuvo Research Inc., a company incorporated under the laws of the province of Ontario, Canada (“NUVO”), having offices at 7560 Airport Road, Unit 10, Mississauga, Ontario, L4T 4H4, and Horizon Pharma Ireland Limited, a Irish limited company (“Horizon Pharma”), having an office at Adelaide Chambers, Peter Street, Dublin 8, Ireland. NUVO and Horizon Pharma each may be referred to herein individually as a “Party,” or collectively as the “Parties.”
SUPPLY AGREEMENTSupply Agreement • April 10th, 2015 • Horizon Pharma PLC • Pharmaceutical preparations
Contract Type FiledApril 10th, 2015 Company IndustryTHIS SUPPLY AGREEMENT (“Agreement”) is made and entered into effective as of October 17, 2014 (the “Effective Date”), by and between Nuvo Research Inc., a company incorporated under the laws of the province of Ontario, Canada (“NUVO”), having offices at 7560 Airport Road, Unit 10, Mississauga, Ontario, L4T 4H4, and Horizon Pharma Ireland Limited, a Irish limited company (“Horizon Pharma”), having an office at Adelaide Chambers, Peter Street, Dublin 8, Ireland. NUVO and Horizon Pharma each may be referred to herein individually as a “Party,” or collectively as the “Parties.”